Literature DB >> 8699927

Vibrio vulnificus hemolysin dilates rat thoracic aorta by activating guanylate cyclase.

H Kook1, S E Lee, Y H Baik, S S Chung, J H Rhee.   

Abstract

Hemolysin produced by Vibrio vulnificus caused hypotension and tachycardia in rats and dilated rat thoracic aorta. Hemolysin-induced vasodilatation of the aorta was not affected by N omega-nitro-L-arginine methyl ester and aminoguanidine, NO synthase inhibitors, whereas the vasodilatation was inhibited by LY 83,583, a guanylate cyclase inhibitor. Hemolysin elevated cGMP levels, and the elevation was abolished by LY 83,583. These results suggest that V. vulnificus hemolysin activates guanylate cyclase independently of NO synthase, and the subsequent increase in cGMP levels results in vasodilatation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699927     DOI: 10.1016/0024-3205(96)00292-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Detection of cytotoxin-hemolysin mRNA in nonculturable populations of environmental and clinical Vibrio vulnificus strains in artificial seawater.

Authors:  Marion Fischer-Le Saux; Dominique Hervio-Heath; Solen Loaec; Rita R Colwell; Monique Pommepuy
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

4.  Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice.

Authors:  Karen E Cerveny; Angelo DePaola; Donna H Duckworth; Paul A Gulig
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Vibrio vulnificus has the transmembrane transcription activator ToxRS stimulating the expression of the hemolysin gene vvhA.

Authors:  S E Lee; S H Shin; S Y Kim; Y R Kim; D H Shin; S S Chung; Z H Lee; J Y Lee; K C Jeong; S H Choi; J H Rhee
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

6.  Evidence that expression of the Vibrio vulnificus hemolysin gene is dependent on cyclic AMP and cyclic AMP receptor protein.

Authors:  Y B Bang; S E Lee; J H Rhee; S H Choi
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

7.  Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients.

Authors:  Young Ran Kim; Shee Eun Lee; Choon Mee Kim; Soo Young Kim; Eun Kyoung Shin; Dong Hyeon Shin; Sun Sik Chung; Hyon E Choy; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Joon Haeng Rhee
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Effects of temperature, growth phase and luxO-disruption on regulation systems of toxin production in Vibrio vulnificus strain L-180, a human clinical isolate.

Authors:  Abdelaziz Elgaml; Kazutaka Higaki; Shin-ichi Miyoshi
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

9.  In situ and in vitro gene expression by Vibrio vulnificus during entry into, persistence within, and resuscitation from the viable but nonculturable state.

Authors:  Ben Smith; James D Oliver
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

10.  Identification and characterization of a repeat-in-toxin gene cluster in Vibrio anguillarum.

Authors:  Ling Li; Jessica L Rock; David R Nelson
Journal:  Infect Immun       Date:  2008-03-31       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.